Kiniksa Pharmaceuticals International Plc logo

Kiniksa Pharmaceuticals International Plc Share Price (NASDAQ: KNSA)

$33.49

-0.01

(-0.03%)

Last updated on

Check the interactive Kiniksa Pharmaceuticals International Plc Stock chart to analyse performance

Kiniksa Pharmaceuticals International Plc stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$33.29
    Today's High:$33.61

    Day's Volatility :0.95%

  • 52 Weeks Low:$17.82
    52 Weeks High:$34.55

    52 Weeks Volatility :48.42%

Kiniksa Pharmaceuticals International Plc Stock Returns

PeriodKiniksa Pharmaceuticals International PlcSector (Health Care)Index (Russel 2000)
3 Months
19.97%
3.6%
0.0%
6 Months
56.08%
-7.7%
0.0%
1 Year
28.78%
-12.6%
0.0%
3 Years
179.82%
9.5%
-4.7%

Kiniksa Pharmaceuticals International Plc Key Stats

Check Kiniksa Pharmaceuticals International Plc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$33.5
Open
$33.59
Today's High
$33.61
Today's Low
$33.29
Market Capitalization
$2.5B
Today's Volume
$316.9K
52 Week High
$34.5455
52 Week Low
$17.82
Revenue TTM
$529.3M
EBITDA
$6.0M
Earnings Per Share (EPS)
$0.05
PE Ratio
669.8
Profit Margin
0.9%
Quarterly Earnings Growth YOY
5.5%
Return On Equity TTM
1.03%

Stock Returns calculator for Kiniksa Pharmaceuticals International Plc Stock including INR - Dollar returns

The Kiniksa Pharmaceuticals International Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Kiniksa Pharmaceuticals International Plc investment value today

Current value as on today

₹1,34,042

Returns

₹34,042

(+34.04%)

Returns from Kiniksa Pharmaceuticals International Plc Stock

₹28,758 (+28.76%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Kiniksa Pharmaceuticals International Plc Stock

194%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Kiniksa Pharmaceuticals International Plc Stock from India on INDmoney has increased by 194% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Kiniksa Pharmaceuticals International Plc

  • Name

    Holdings %

  • Rubric Capital Management LP

    5.28%

  • BlackRock Inc

    4.63%

  • Vanguard Group Inc

    4.23%

  • Baker Bros Advisors LP

    3.81%

  • TANG CAPITAL MANAGEMENT LLC

    3.14%

  • Fairmount Funds Management LLC

    2.39%

Analyst Recommendation on Kiniksa Pharmaceuticals International Plc Stock

Rating
Trend

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Kiniksa Pharmaceuticals International Plc(by analysts ranked 0 to 5 stars)

Kiniksa Pharmaceuticals International Plc Share Price Target

What analysts predicted

Upside of 38.85%

Target:

$46.50

Current:

$33.49

Kiniksa Pharmaceuticals International Plc share price target is $46.50, a slight Upside of 38.85% compared to current price of $33.49 as per analysts' prediction.

Kiniksa Pharmaceuticals International Plc Stock Insights

  • Price Movement

    In the last 6 months, KNSA stock has moved up by 65.2%
  • Increasing Revenue

    Revenue is up for the last 6 quarters, 79.85M → 156.79M (in $), with an average increase of 12.3% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, -12.69M → 17.83M (in $), with an average increase of 99.7% per quarter

Kiniksa Pharmaceuticals International Plc Technicals Summary

Sell

Neutral

Buy

Kiniksa Pharmaceuticals International Plc is currently in a neutral trading position according to technical analysis indicators.

Kiniksa Pharmaceuticals International Plc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Kiniksa Pharmaceuticals International Plc logo
10.69%
56.08%
28.78%
179.82%
101.78%
Haleon Plc Spon Ads logo
1.5%
-7.33%
-3.49%
69.05%
32.32%
United Therapeutics Corporation logo
3.57%
-1.69%
-13.51%
34.83%
71.41%
Zoetis Inc. logo
6.13%
-8.28%
-14.8%
-1.88%
-3.48%
Neurocrine Biosciences Inc. logo
8.29%
21.94%
11.59%
32.16%
20.59%

About Kiniksa Pharmaceuticals International Plc

Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Vixarelimab, a monoclonal antibody, that is in Phase 2b clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-387, an investigational, that is in Phase 2/3 clinical trial for human immunoglobulin G2 monoclonal antibody that binds human interleukin-1 receptor 1, inhibiting IL-1a, IL-1ß-mediated signaling for the treatment of advance recurrent pericarditis by providing the added convenience of monthly subcutaneous dosing with a liquid formulation. Its preclinical products include KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody. The company was formerly known as Kiniksa Pharmaceuticals, Ltd and changed its name tpKiniksa Pharmaceuticals International, plc in June 2024. The company was incorporated in 2015 and is based in London, the United Kingdom.
Organization
Kiniksa Pharmaceuticals International Plc
Employees
315
CEO
Mr. Sanj K. Patel
Industry
Health Technology

Key Management of Kiniksa Pharmaceuticals International Plc

NameTitle
Mr. Sanj K. Patel
CEO & Chairman of the Board
Mr. Mark A. Ragosa C.F.A.
Senior VP & CFO
Mr. Eben Tessari
Executive VP & COO
Dr. John F. Paolini FACC, M.D., Ph.D.
Executive VP & Chief Medical Officer
Mr. Ross Michael Moat
Executive VP & Chief Commercial Officer
Mr. Michael R. Megna CPA
Chief Accounting Officer & Group VP of Finance
Ms. Mei Jang
Senior Vice President of Technical Operations
Jonathan Kirshenbaum
Investor Relations Officer

Important FAQs about investing in KNSA Stock from India :

What is Kiniksa Pharmaceuticals International Plc share price today?

Kiniksa Pharmaceuticals International Plc share price today is $33.49 as on at the close of the market. Kiniksa Pharmaceuticals International Plc share today touched a day high of $33.61 and a low of $33.29.

What is the 52 week high and 52 week low for Kiniksa Pharmaceuticals International Plc share?

Kiniksa Pharmaceuticals International Plc share touched a 52 week high of $34.55 and a 52 week low of $17.82. Kiniksa Pharmaceuticals International Plc stock price today i.e. is closed at $33.49, lower by 3.06% versus the 52 week high.

How to invest in Kiniksa Pharmaceuticals International Plc Stock (KNSA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kiniksa Pharmaceuticals International Plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kiniksa Pharmaceuticals International Plc Shares that will get you 0.0448 shares as per Kiniksa Pharmaceuticals International Plc share price of $33.49 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Kiniksa Pharmaceuticals International Plc Stock (KNSA) from India?

Indian investors can start investing in Kiniksa Pharmaceuticals International Plc (KNSA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Kiniksa Pharmaceuticals International Plc stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Kiniksa Pharmaceuticals International Plc share’s latest price of $33.49 as on August 30, 2025 at 1:29 am IST, you will get 0.2986 shares of Kiniksa Pharmaceuticals International Plc. Learn more about fractional shares .

What are the returns that Kiniksa Pharmaceuticals International Plc has given to Indian investors in the last 5 years?

Kiniksa Pharmaceuticals International Plc stock has given 101.78% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?